Filter by Type

Identifying relevant KOLs on a global scale
A biopharmaceutical company that discovers, develops, and markets products and services globally to support research, diagnostics, and molecular biology markets.

Quickly finding global prospects with healthcare commercial intelligence
A global medical device company develops and manufactures high-performance scientific instruments and diagnostic solutions to improve productivity and patient outcomes in the life science industry.

Driving impact and value: Tailored engagement strategies
Download our whitepaper to learn how the right data and analytics can help medical science liaisons engage more effectively with experts.

Enabling a brand to move from a later- to earlier line of therapy for a highly prevalent chronic disease
A leading biopharma company had an inline brand for a large primary care market and was eager to expand the brand’s market from a predominately late line of therapy to an earlier line of therapy in the patient’s treatment pathway.

Optimize promotional planning while reducing consultant dependencies
A large pharmaceutical company wanted a self-service analytics solution that 1) optimized promotional modeling, 2) evaluated the returns on marketing investments, and 3) decreased costs associated with consultants performing analyses.

Optimizing marketing and sales investments across brands and regions
An established pharmaceutical manufacturer needed to optimize marketing and sales investments across regions while identifying risks and opportunities within the revenue stream.

Top 20 hospitals treating digestive disorders by percentage of unique patients
Discover the top 20 hospitals by percentage of unique patients for digestive disorders in 2022 through October.

Expanding the HCP target list for a new drug used to treat a rare disease in children
A pharmaceutical company needed to increase adoption of their new drug used to treat a rare disease in children. Using Passport Planning and Performance, the company substantially grew their target list of HCPs likely to treat patients with the rare…